(Total Views: 117)
Posted On: 07/17/2023 8:50:48 AM
Post# of 144704
$CMPS News Article - COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology https://marketwirenews.com/news-releases/comp...36233.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
